The Valley Desk

ArticlePharmacoEconomics - openPublished

Prevalence and Healthcare Costs of Metabolic Disorders Among Individuals with Schizophrenia Following Initiation of Oral Antipsychotic Therapy

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

Publication record

Type
Article
Venue
PharmacoEconomics - open
Published
PubMed ID
41912979
PubMed Central ID
PMC13194814
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal